RaucaffricineCAS# 31282-07-2 |
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
| Cas No. | 31282-07-2 | SDF | Download SDF |
| PubChem ID | 20056255 | Appearance | Powder |
| Formula | C27H32N2O8 | M.Wt | 512.56 |
| Type of Compound | Alkaloids | Storage | Desiccate at -20°C |
| Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
| SMILES | CC=C1C2CC3C4=NC5=CC=CC=C5C46CC(C2C6OC(=O)C)N3C1OC7C(C(C(C(O7)CO)O)O)O | ||
| Standard InChIKey | OSJPGOJPRNTSHP-BGYCQZOHSA-N | ||
| Standard InChI | InChI=1S/C27H32N2O8/c1-3-12-13-8-16-23-27(14-6-4-5-7-15(14)28-23)9-17(19(13)24(27)35-11(2)31)29(16)25(12)37-26-22(34)21(33)20(32)18(10-30)36-26/h3-7,13,16-22,24-26,30,32-34H,8-10H2,1-2H3/b12-3+/t13-,16-,17-,18+,19?,20+,21-,22+,24?,25+,26-,27+/m0/s1 | ||
| General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
| About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
| Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. | ||
| Structure Identification | J Enzyme Inhib Med Chem. 2015 Jun;30(3):472-8.Ligand structures of synthetic deoxa-pyranosylamines with raucaffricine and strictosidine glucosidases provide structural insights into their binding and inhibitory behaviours.[Pubmed: 25140865]
|
Raucaffricine Dilution Calculator
Raucaffricine Molarity Calculator
| 1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
| 1 mM | 1.951 mL | 9.755 mL | 19.5099 mL | 39.0198 mL | 48.7748 mL |
| 5 mM | 0.3902 mL | 1.951 mL | 3.902 mL | 7.804 mL | 9.755 mL |
| 10 mM | 0.1951 mL | 0.9755 mL | 1.951 mL | 3.902 mL | 4.8775 mL |
| 50 mM | 0.039 mL | 0.1951 mL | 0.3902 mL | 0.7804 mL | 0.9755 mL |
| 100 mM | 0.0195 mL | 0.0975 mL | 0.1951 mL | 0.3902 mL | 0.4877 mL |
| * Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. | |||||
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Hygromycin B
Catalog No.:BCC1204
CAS No.:31282-04-9
- Indacaterol
Catalog No.:BCC1650
CAS No.:312753-06-3
- gamma-Mangostin
Catalog No.:BCN5228
CAS No.:31271-07-5
- THIQ
Catalog No.:BCC7539
CAS No.:312637-48-2
- SKI II
Catalog No.:BCC5029
CAS No.:312636-16-1
- Tetrahydrocannabivarin
Catalog No.:BCN6935
CAS No.:31262-37-0
- IQ 3
Catalog No.:BCC8093
CAS No.:312538-03-7
- Cimigenol-3-one
Catalog No.:BCN7430
CAS No.:31222-32-9
- Eucalyptin
Catalog No.:BCN5227
CAS No.:3122-88-1
- Sideroxylin
Catalog No.:BCN5226
CAS No.:3122-87-0
- H-D-Ser-OH
Catalog No.:BCC2676
CAS No.:312-84-5
- Methylionene
Catalog No.:BCN7120
CAS No.:31197-54-3
- TCS JNK 5a
Catalog No.:BCC5148
CAS No.:312917-14-9
- LDN-27219
Catalog No.:BCC6236
CAS No.:312946-37-5
- Arjunic acid
Catalog No.:BCN5229
CAS No.:31298-06-3
- Estradiol Cypionate
Catalog No.:BCC4477
CAS No.:313-06-4
- Aristolochic acid A
Catalog No.:BCN6262
CAS No.:313-67-7
- ICA 121431
Catalog No.:BCC6358
CAS No.:313254-51-2
- Regadenoson
Catalog No.:BCC6438
CAS No.:313348-27-5
- Reversan
Catalog No.:BCC7764
CAS No.:313397-13-6
- VU 590 dihydrochloride
Catalog No.:BCC7803
CAS No.:313505-85-0
- T0070907
Catalog No.:BCC2261
CAS No.:313516-66-4
- INH1
Catalog No.:BCC6040
CAS No.:313553-47-8
- Bombesin
Catalog No.:BCC5708
CAS No.:31362-50-2
Ligand structures of synthetic deoxa-pyranosylamines with raucaffricine and strictosidine glucosidases provide structural insights into their binding and inhibitory behaviours.[Pubmed:25140865]
J Enzyme Inhib Med Chem. 2015 Jun;30(3):472-8.
Insight into the structure and inhibition mechanism of O-beta-d-glucosidases by deoxa-pyranosylamine type inhibitors is provided by X-ray analysis of complexes between Raucaffricine and strictosidine glucosidases and N-(cyclohexylmethyl)-, N-(cyclohexyl)- and N-(bromobenzyl)-beta-d-gluco-1,5-deoxa-pyranosylamine. All inhibitors anchored exclusively in the catalytic active site by competition with appropriate enzyme substrates. Thus facilitated prospective elucidation of the binding networks with residues located at <3.9 A distance will enable the development of potent inhibitors suitable for the production of valuable alkaloid glucosides, Raucaffricine and strictosidine, by means of synthesis in Rauvolfia serpentina cell suspension cultures.
